RxDoctor Payments DataLook up a doctor →

Deborah Graf

Nurse Practitioner · Powell, TNNPI 1003992421

Payments from drug & device makers

$13,749in general payments, 2019–2025

Across 712 payments — averaging $19.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Johnson & Johnson$909
  • Merck$717
  • Amgen$609
  • E.r. Squibb & Sons, L.L.C.$586
  • Genentech USA, Inc.$541
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$13,46898%
  • Education$2812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)50$1,005
Johnson & Johnson47$909
Merck35$717
Amgen35$609
E.r. Squibb & Sons, L.L.C.41$586
Genentech USA, Inc.27$541
Seagen Inc.35$532
Incyte Corporation24$517
Pfizer27$500
AbbVie28$491
Daiichi Sankyo Inc.21$456
Novartis23$453
Sanofi24$441
GSK24$435
Eisai Inc.21$401
Astellas Pharma US Inc22$399
Bristol Myers Squibb24$385
AVEO Pharmaceuticals, Inc.10$318
Takeda Pharmaceuticals U.S.A., Inc.13$288
Regeneron Healthcare Solutions, Inc.9$248
Pharmacyclics LLC, An Abbvie Company15$240
Gilead13$237
Mirati Therapeutics, Inc.8$237
Bayer13$233
Lilly USA, LLC11$200
Epizyme, Inc.8$189
Deciphera Pharmaceuticals Inc.8$184
Sanofi-aventis U.S. LLC2$182
Puma Biotechnology, Inc.9$173
Karyopharm Therapeutics Inc.6$170
Blueprint Medicines Corporation5$129
Exelixis Inc.6$122
Sobi, Inc5$105
Genmab U.S., Inc.4$83
EMD Serono, Inc.4$79
Rigel Pharmaceuticals, Inc.4$68
Myriad Genetic Laboratories, Inc.4$67
Acceleron Pharma, Inc.4$66
Pharmacosmos Therapeutics Inc.3$64
Servier Pharmaceuticals LLC3$56
Tersera Therapeutics LLC3$49
Clovis Oncology, Inc.3$47
Dova Pharmaceuticals3$45
Array Biopharma Inc2$43
Jazz Pharmaceuticals Inc.3$41
Taiho Oncology, Inc.3$40
Boehringer Ingelheim2$37
Stemline Therapeutics Inc.2$37
Beone Medicines USA, Inc.2$37
Ipsen Biopharmaceuticals, Inc2$34
Pharmaessentia USA Corporation1$23
Immunogen, Inc.1$23
G1 Therapeutics, Inc.1$22
TG Therapeutics, Inc.1$21
Verity Pharmaceuticals Inc.1$19
Kyowa Kirin, Inc.1$18
Geron Corporation1$18
Morphosys, US Inc.1$18
Adaptive Biotechnologies Corporation1$18
Beigene USA, Inc.1$17

How this compares

$13,749 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$3,135
Medicare patients
26
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban11$8,218
Oxycodone Hcl34$677
Tamoxifen Citrate16$668
ValacyclovirValacyclovir Hcl11$594
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$573
Ondansetron OdtOndansetron31$454
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$418
Prochlorperazine Maleate28$350
Potassium Chloride27$221
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine11$177
Raloxifene Hcl11$152
Gabapentin19$150
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$146
Anastrozole20$145
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$122

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$909$8,21811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Powell

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →